System Transmission

Top Signal

100#1 JOB

Activity

2188Ripe

+949 today

System

Live1m

Terminal Asset View

stockNASDAQ

ENTX

$1.27-3.79%

Entera Bio Ltd

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

13Overripe

Live Analysis Active

Company Mission

Entera Bio Ltd creates oral drug delivery systems for diseases such as osteoporosis, allowing patients to take medications by mouth instead of injections. Doctors and patients use these products because they are more convenient and less invasive. The company makes money by licensing its technology to pharmaceutical partners and through potential drug sales.

ENT

Industry Context

Entera Bio operates in the biotechnology sector, focusing on innovative drug delivery methods. This industry is highly competitive, with companies racing to develop easier treatments for chronic conditions. Success often depends on clinical trial results and regulatory approvals, making it a high-risk, high-reward field.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

52Matrix

Market Momentum

42.2— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.5x— Normal Volume

Today's Change

-3.79%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing ENTX across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 06:05 AM UTC

As-of As of 2026-03-16T05:50:05.081Z UTC (~15m delay).

Develops oral drug delivery technology for patients who struggle with injections, aiming to generate revenue through partnerships and future product sales.

Weekly chart shows range contraction near $1, indicating a coiling pattern that often precedes breakouts. Watch for a decisive move above this level.

Volume spiked 3x at $1, indicating buyer interest because it coincided with positive trial news. Monitor if volume stays above average.

Biotech sector recovery is driving strength, with price holding above $1.50, signaling resilience. Watch for industry trends like FDA approvals.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...